The cGAS-STING pathway in cancer: friend or foe

Qian Li1,2,3,4, Qingkang Song1,2,3,4, Lingli Ma1,2,3,4

  • 1NHC Key Laboratory of Carcinogenesis and Hunan Key Laboratory of Cancer Metabolism, Hunan Cancer Hospital and the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China.

Cell Death & Disease
|March 26, 2026
PubMed

Insights

The cyclic GMP-AMP synthase (cGAMP) synthase (cGAS)-stimulator of interferon genes (STING) pathway detects cytoplasmic DNA to trigger immunity. This pathway has dual roles in cancer, activating anti-tumor responses while sometimes promoting tumor growth.

Area of Science:

  • Immunology
  • Molecular Biology
  • Cancer Research

Background:

  • The cGAS-STING pathway is a key innate immune sensor for aberrant cytoplasmic DNA.
  • Activation of cGAS by DNA leads to the production of cGAMP, which signals through STING to induce type I interferons.
  • This pathway plays a complex role in tumor immunity, with both anti-tumor and pro-tumor effects.

Purpose of the Study:

  • To review the mechanisms by which the cGAS-STING pathway is regulated.
  • To delineate the dual roles of the cGAS-STING axis in tumor immunity.
  • To survey immunotherapy strategies targeting the cGAS-STING pathway.

Main Methods:

  • Literature review of studies on the cGAS-STING pathway in cancer.
  • Analysis of mechanisms controlling cGAS activation and STING signaling.
  • Evaluation of evidence for both anti-tumor and pro-tumor functions.

Main Results:

  • The review clarifies safeguards preventing cGAS from sensing nuclear self-DNA.
  • It details how the cGAS-STING pathway can both promote anti-tumor immunity and support tumor progression.
  • Various immunotherapy strategies targeting this axis are discussed.

Conclusions:

  • The cGAS-STING pathway is a critical regulator of the tumor immune microenvironment.
  • Understanding its dual functions is essential for developing effective cancer immunotherapies.
  • Targeting the cGAS-STING pathway holds significant promise for cancer treatment.

Related Concept Videos

Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.9K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.3K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

4.2K
Intracellular Signaling Cascades01:24

Intracellular Signaling Cascades

Once a ligand binds to a receptor, the signal is transmitted through the membrane and into the cytoplasm. The continuation of a signal in this manner is called signal transduction. Signal transduction only occurs with cell-surface receptors, which cannot interact with most components of the cell, such as DNA. Only internal receptors can interact directly with DNA in the nucleus to initiate protein synthesis. When a ligand binds to its receptor, conformational changes occur that affect the...
55.1K
Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
3.5K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
9.2K